Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Director departure
Appointed director
VOLITIONRX LTD (VNRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 4 Butera Salvatore Thomas (CEO - Volition Veterinary) has filed a Form 4 on VOLITIONRX LTD
Txns: Paid exercise price by delivering 5,834 shares @ $0.675, valued at $3.9k
10/06/2023 4 Faulkes Martin Charles (Director) has filed a Form 4 on VOLITIONRX LTD
Txns: Paid exercise price by delivering 5,850 shares @ $0.675, valued at $3.9k
10/06/2023 4 Michel Gaetan (COO) has filed a Form 4 on VOLITIONRX LTD
Txns: Paid exercise price by delivering 15,412 shares @ $0.675, valued at $10.4k
10/06/2023 4 Forterre Gael (Chief Commercial Officer) has filed a Form 4 on VOLITIONRX LTD
Txns: Paid exercise price by delivering 5,527 shares @ $0.675, valued at $3.7k
08/25/2023 4 Kway Jasmine (CEO - Singapore Volition) has filed a Form 4 on VOLITIONRX LTD
Txns: Bought 5,000 shares @ $1.2, valued at $6k
08/25/2023 4 Futcher Edward (Director) has filed a Form 4 on VOLITIONRX LTD
Txns: Bought 5,000 shares @ $1.22, valued at $6.1k
08/24/2023 4 Michel Gaetan (COO) has filed a Form 4 on VOLITIONRX LTD
Txns: Bought 5,000 shares @ $1.23, valued at $6.2k
08/17/2023 4 Butera Salvatore Thomas (CEO - Volition Veterinary) has filed a Form 4 on VOLITIONRX LTD
Txns: Bought 8,000 shares @ $1.21, valued at $9.7k
08/16/2023 4 Reynolds Cameron John (President and CEO) has filed a Form 4 on VOLITIONRX LTD
Txns: Bought 10,000 shares @ $1.22, valued at $12.2k
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/14/2023 8-K Quarterly results
Docs: "VolitionRx Limited Announces Second Quarter 2023 Financial Results and Business Update Conference call to discuss financial and operational results scheduled for Tuesday, August 15, at 8:30 a.m. U.S. Eastern Time Henderson, Nevada, August 14, 2023 /PRNewswire/ -- VolitionRx Limited today announced financial results and a business update for the second quarter ended June 30, 2023. Volition management will host a conference call tomorrow, August 15 at 8:30 a.m. U.S. Eastern Time to discuss these results. Conference call details can be found below. "I am delighted to report that we submitted a Breakthrough Device Designation Request to the FDA in June for our Nu.Q ® technology in relation to sepsis. This was a milestone moment in our company’s history and for the first time we are in active ..."
08/07/2023 4 Batchelor Ann-Louise (Group Chief Marketing Officer) has filed a Form 4 on VOLITIONRX LTD
Txns: Paid exercise price by delivering 5,819 shares @ $1.3, valued at $7.6k
08/07/2023 4 Rootsaert Rodney Gerard (Secretary) has filed a Form 4 on VOLITIONRX LTD
Txns: Paid exercise price by delivering 4,850 shares @ $1.3, valued at $6.3k
08/07/2023 4 Faulkes Martin Charles (Director) has filed a Form 4 on VOLITIONRX LTD
Txns: Paid exercise price by delivering 5,427 shares @ $1.3, valued at $7.1k
08/07/2023 4 Micallef Jacob Vincent (Chief Scientific Officer) has filed a Form 4 on VOLITIONRX LTD
Txns: Paid exercise price by delivering 5,427 shares @ $1.3, valued at $7.1k
07/14/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
07/07/2023 4 Batchelor Ann-Louise (Group Chief Marketing Officer) has filed a Form 4 on VOLITIONRX LTD
Txns: Granted 17,550 shares @ $0
07/07/2023 4 Colman Alan (Director) has filed a Form 4 on VOLITIONRX LTD
Txns: Granted 6,750 shares @ $0
07/07/2023 4 Hughes Terig (CFO) has filed a Form 4 on VOLITIONRX LTD
Txns: Granted 24,750 shares @ $0
07/07/2023 4 Faulkes Martin Charles (Director) has filed a Form 4 on VOLITIONRX LTD
Txns: Granted 17,550 shares @ $0
07/07/2023 4 Butera Salvatore Thomas (CEO - Volition Veterinary) has filed a Form 4 on VOLITIONRX LTD
Txns: Granted 28,800 shares @ $0
07/07/2023 4 Reynolds Cameron John (President and CEO) has filed a Form 4 on VOLITIONRX LTD
Txns: Granted 40,050 shares @ $0
07/07/2023 4 Rootsaert Rodney Gerard (Secretary) has filed a Form 4 on VOLITIONRX LTD
Txns: Granted 14,850 shares @ $0
07/07/2023 4 Futcher Edward (Director) has filed a Form 4 on VOLITIONRX LTD
Txns: Granted 6,750 shares @ $0
07/07/2023 4 Nguyen Kim (Director) has filed a Form 4 on VOLITIONRX LTD
Txns: Granted 6,750 shares @ $0
07/07/2023 4 Barnes Phillip (Director) has filed a Form 4 on VOLITIONRX LTD
Txns: Granted 6,750 shares @ $0
07/07/2023 4 Kway Jasmine (CEO - Singapore Volition) has filed a Form 4 on VOLITIONRX LTD
Txns: Granted 22,050 shares @ $0
07/07/2023 4 Forterre Gael (Chief Commercial Officer) has filed a Form 4 on VOLITIONRX LTD
Txns: Granted 20,700 shares @ $0
07/07/2023 4 Michel Gaetan (COO) has filed a Form 4 on VOLITIONRX LTD
Txns: Granted 33,300 shares @ $0
07/07/2023 4 Micallef Jacob Vincent (Chief Scientific Officer) has filed a Form 4 on VOLITIONRX LTD
Txns: Granted 17,550 shares @ $0
07/07/2023 4 Innes Guy Archibald (Director) has filed a Form 4 on VOLITIONRX LTD
Txns: Granted 6,750 shares @ $0
07/07/2023 4 Plummer Nicholas (GC - Volition Diagnostics) has filed a Form 4 on VOLITIONRX LTD
Txns: Granted 23,400 shares @ $0
06/30/2023 8-K Appointed a new director
Docs: "2015 Stock Incentive Plan, as amended"
06/29/2023 4 Innes Guy Archibald (Director) has filed a Form 4 on VOLITIONRX LTD
Txns: Gifted 1,000,000 shares @ $0
Gifted 1,000,000 shares @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy